Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Cefixime Trihydrate 100 mg/5 mL DS
NCT04982861Completed
- Sponsor
- Bernofarm
- Start
- Jun 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of cefixime in bacterial infection (2 arms), sponsored by Bernofarm. Primary endpoints: Geometric Mean Ratio at 32 hours and 90% Confidence Intervals at 32 hours. Started Jun 2020; status: completed.
02
Drugs
cefixime
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04982861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04982861.